Uncategorized Podcasts

Episode 28 – Skyfill and unsustainable sustainability with Jim Lane

Episode 28 – Skyfill and unsustainable sustainability with Jim Lane

In this episode, I have the great pleasure of having our first omnipresent guest, Jim Lane, who is everywhere within the biobased economy with his leading daily publication The Digest. In the midst of driving the Bold Goals Initiative, catalysed by the US Inflation Reduction Act, and running the Advanced Bioeconomy Leadership Conference (ABLC), we catch up with Jim on current perspectives on the bioeconomy and a little soothsaying on what the next few years might look like.

read more
Episode 27 – The National Innovation Forum Prequel with Catherine Livingstone and David Thodey

Episode 27 – The National Innovation Forum Prequel with Catherine Livingstone and David Thodey

I’m delighted to bring you a special podcast leading up to the 2023 National Innovation Policy Forum, presented by Cooperative Research Australia, to bring leaders from business, government, research – and boundary spanning organisations to focus on the future of the Australian innovation system.

 I had the opportunity to have a pre-forum conversation with co-patrons Catherine Livingstone AO and David Thodey AO for their thoughts on the current innovation landscape, the role of policy, and the importance of a shared vision for Australia’s future.

read more
Episode 26 – Alt-protein and emerging growth factors with Maurice Moloney

Episode 26 – Alt-protein and emerging growth factors with Maurice Moloney

In this episode, I have the great pleasure of having our first guest, Maurice Moloney, make a return appearance to revisit what’s been happening in protein over the past two years since our first discussion. Coming off the back of the International Rapeseed Congress (in September 2023), we explore the decline, or indeed collapse, of the alt-meat market and what the prospects are for it reaching its next growth phase.

read more
Episode 25 – The bravery to act first and leading new product commercialisation with Shona Faber

Episode 25 – The bravery to act first and leading new product commercialisation with Shona Faber

In this episode, my guest is Shona Faber, Non-Executive Director of ARB Corporation, previously Managing Director CRC Industries, and General Manager of Specialty Gases & Chemicals at BOC. We talk about her experiences in bringing EDN, a novel fumigant chemical, licensed from CSIRO Entomology to market in her role at BOC. In discussing the journey that unfolded in this product coming to market, we touch on risk management and managing constant change as a new chemical is shepherded through various regulatory systems to market.

read more
Episode 24 – Regional Innovation Ecosystems with Elena Kelareva

Episode 24 – Regional Innovation Ecosystems with Elena Kelareva

In this episode we talk with Elena Kelareva, CEO and Founder of GippsTech, about her experiences in establishing innovation systems in regional areas, and her reflections on the behavioural and cultural settings behind successful regional innovation ecosystems. We touch on the definition of tech transfer and tease out a distinction between innovation translating scientific outcomes and entrepreneurship, the latter being more broadly around the establishment of ventures to address new opportunities.

read more
Episode 23 – Joining the dots and the secret sauce with Cameron Hibbert

Episode 23 – Joining the dots and the secret sauce with Cameron Hibbert

In this episode we had the chance to catch up with Cameron Hibbert, a long-standing colleague and friend who has been in global licensing roles at LyondellBassell Industries and Genomatica. We talk about when I first met Cameron at Montell and his journey to Germany through carrying responsibility for technology transfer at the Geelong polypropylene production plant. We explore his experiences moving from licensee to licensor in his role with LyondellBassell Industries taking responsibility for polyolefin licensing activities.

read more
Episode 22 – Leadership and Relationships with Paul Wood

Episode 22 – Leadership and Relationships with Paul Wood

In this episode, we were pleased to have a wide-ranging discussion with Paul Wood. We talk about his start at CSIRO and the pathway to his breakthrough in TB tests for cattle in the Northern Territory, and how it opened a pathway into animal and human health research leadership. We discuss a few ‘sliding door’ moments with Paul around Qiagen, Cellestis, CSL and Pfizer, and how he ended up with the ‘keys to the lolly shop’ with Pfizer Animal Health (now Zoetis) in North America.

read more
Episode 21 – Axon Instruments and the Relentless Commitment to Quality with Alan Finkel

Episode 21 – Axon Instruments and the Relentless Commitment to Quality with Alan Finkel

In this episode, I have the great privilege of chatting with Alan Finkel. We revisit key formative moments at Monash University and ANU, and the opportunities that emerged from the challenge of accessing and developing the best fit for purpose equipment. We discuss the difference between framing questions and solving problems through a discussion of the Engineering Method, an approach that underpins Alan’s career at Axon Instruments and beyond. Through instrument development, Alan recognises that development needs to be orientated towards needs, those spoken and those yet to be identified, and move past ‘what a customer wants’.

read more
Episode 20 – Hopium, Hydrogen & Scale with Paul Martin – Part 2

Episode 20 – Hopium, Hydrogen & Scale with Paul Martin – Part 2

In this episode we continue our discussions with Paul Martin exploring the challenges of clean hydrogen scale up, the market forces and Hopium driving current government and industry activity. We discuss distributed production of ammonia and urea and the impact of diseconomies of scale and consequences of parallelisation. We reflect on alternative feedstocks, such as lignocellulose, with a passing nod to our mutual colleague Paul Bryan, and how Wright’s Law of the cost benefits arising from increasing scale and experience may not apply as anticipated by many in the race to scale green hydrogen production.

read more